FDA committee to discuss lomitapide for hoFH

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Oct. 17 to discuss an NDA from Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) for lomitapide to treat homozygous familial hypercho...